Volume 64, Issue 6, Pages 1388-1402 (June 2016) EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease Journal of Hepatology Volume 64, Issue 6, Pages 1388-1402 (June 2016) DOI: 10.1016/j.jhep.2015.11.004 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Fig. 1 Diagnostic flow-chart to assess and monitor disease severity in the presence of suspected NAFLD and metabolic risk factors. 1Steatosis biomarkers: Fatty Liver Index, SteatoTest, NAFLD Fat score (see Tables). 2Liver tests: ALT AST, γGT. 3Any increase in ALT, AST or γGT. 4Serum fibrosis markers: NAFLD Fibrosis Score, FIB-4, Commercial tests (FibroTest, FibroMeter, ELF). 5Low risk: indicative of no/mild fibrosis; Medium/high risk: indicative of significant fibrosis or cirrhosis (see Tables). Journal of Hepatology 2016 64, 1388-1402DOI: (10.1016/j.jhep.2015.11.004) Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions
Journal of Hepatology 2016 64, 1388-1402DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions